Revolution Medicines (RVMD) Goodwill & Intangibles (2019 - 2026)
Revolution Medicines (RVMD) posted quarterly Goodwill & Intangibles of $70.4 million for Q1 2026, down 9.6% year-over-year from $77.9 million in Q1 2025, and little changed quarter-over-quarter from $70.4 million in Q4 2025.
Revolution Medicines (RVMD) Goodwill & Intangibles (2019 - 2026) Analysis & Trends
Revolution Medicines' Goodwill & Intangibles history runs 8 years deep, the most recent figure standing at $70.4 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 9.6% year-over-year to $70.4 million; the TTM figure through Mar 2026 stood at $70.4 million (down 9.6% YoY), while the FY2025 annual figure was $70.4 million, down 1.22% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $70.4 million, roughly flat from $70.4 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $111.7 million in Q2 2024, with the low at $70.4 million in Q1 2023.
- The 5-year median for Goodwill & Intangibles is $72.6 million (2023), against an average of $75.3 million.
- The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles jumped 53.3% in 2024, then slumped 36.68% in 2025.
- Revolution Medicines' Goodwill & Intangibles stood at $73.4 million in 2022, then dropped by 1.45% to $72.3 million in 2023, then retreated by 1.48% to $71.3 million in 2024, then decreased by 1.22% to $70.4 million in 2025, then changed by 0.0% to $70.4 million in 2026.
- Business Quant data shows RVMD's Goodwill & Intangibles at $70.4 million in Q1 2026, $70.4 million in Q4 2025, and $77.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.89 Mn |
| Mar 31, 2026 | 70.41 Mn |
| Dec 31, 2025 | 70.41 Mn |
| Sep 30, 2025 | 77.89 Mn |
| Jun 30, 2025 | 70.74 Mn |
| Mar 31, 2025 | 77.89 Mn |
| Dec 31, 2024 | 71.28 Mn |
| Sep 30, 2024 | 71.55 Mn |
| Jun 30, 2024 | 111.73 Mn |
| Mar 31, 2024 | 72.08 Mn |
| Dec 31, 2023 | 72.35 Mn |
| Sep 30, 2023 | 72.61 Mn |
| Jun 30, 2023 | 72.88 Mn |
| Mar 31, 2023 | 70.41 Mn |
| Dec 31, 2022 | 73.42 Mn |
| Sep 30, 2022 | 73.15 Mn |
| Jun 30, 2022 | 73.95 Mn |
| Mar 31, 2022 | 77.89 Mn |
| Dec 31, 2021 | 77.89 Mn |
| Sep 30, 2021 | 77.89 Mn |